Paris, France

Anne-Celine Kohler

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anne-Celine Kohler

Introduction

Anne-Celine Kohler is a prominent inventor based in Paris, France. She has made significant strides in the field of MicroElectroMechanical Systems (MEMS) with her innovative approaches to in vivo drug delivery systems. With a total of two patents to her name, her work is paving the way for advancements in medical technology.

Latest Patents

Kohler's latest patents focus on systems, methods, and devices for in vivo delivery using remote actuation of implantable hydrogel MEMS devices. These devices are fabricated entirely from hydrogel materials, such as polyethylene glycol with diacrylate functional groups (PEGDA). The unique properties of these hydrogels can be tuned by varying the molecular weights and percentages of PEGDA monomers. This spatial variation allows for different functionalities within the hydrogel MEMS device. The remote actuation of these devices can be achieved through wave energy applications, including magnetic fields, high-intensity focused ultrasound, and infrared radiation. This innovative approach enables the precise delivery of drugs or other substances at specific times and locations within a patient’s body.

Career Highlights

Kohler is currently affiliated with Columbia University, where she continues her research and development in MEMS technology. Her work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Some of her notable coworkers include Samuel K Sia and Sau Yin Chin, who contribute to her research endeavors and collaborative projects.

Conclusion

Anne-Celine Kohler's contributions to the field of MEMS and in vivo drug delivery systems highlight her innovative spirit and dedication to advancing medical technology. Her patents reflect a commitment to improving patient outcomes through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…